Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results

Basit Öğe Kaydı
dc.contributor.authorEsin, E.
dc.contributor.authorOksuzoglu, O. B. Cakmak
dc.contributor.authorBilici, A.
dc.contributor.authorCicin, I.
dc.contributor.authorAksoy, S.
dc.contributor.authorAlacacioglu, A.
dc.contributor.authorKaplan, M. A.
dc.date.accessioned2024-04-24T17:50:00Z
dc.date.available2024-04-24T17:50:00Z
dc.date.issued2018
dc.departmentDicle Üniversitesien_US
dc.description43rd ESMO Congress (ESMO) -- OCT 19-23, 2018 -- Munich, GERMANYen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Soc Med Oncol,Japanese Soc Med Oncolen_US
dc.identifier.endpage105en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.startpage104en_US
dc.identifier.urihttps://hdl.handle.net/11468/23146
dc.identifier.volume29en_US
dc.identifier.wosWOS:000459277300323
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofAnnals of Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titlePertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice resultsen_US
dc.titlePertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu